Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Aarti Drugs Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Key Information

Market Cap

48989171712

Current Price

536.75

52 Week Range

312.0 - 635.0

Previous Close

545.05

Open

549.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Mahendra Industrial Estate, Ground Floor Road No. 29, Plot No. 109-D Sion (East), Mumbai, 400 022, India

Phone

+91-22240-19025

Fax

+91-22240-73462

Website

https://www.aartidrugs.co.in

Financials

Day Low

531.6

Day High

551.25

Dividend Yield

0.18

PE Ratio

25.980156

Earnings Per Share

20.66

Beta

0.41

EBITDA

2957507840

Book Value

149.836

EPS

24.5

Company Officers

Name	Title	Age	Year Born
Mr. Prakash Moreshwar Patil	Chairman, MD, CEO & Head of BR	77	1947
Mr. Harshit Manila Savla	Joint MD & Executive Director	62	1962
Mr. Adhish Prakash Patil	CFO & COO	41	1983
Mr. Rushikesh Vivek Deole	Company Secretary & Compliance Officer	-	-
Mr. Harit Pragji Shah	Whole-Time Director	61	1963
Mr. Uday Moreshwar Patil	Whole-Time Director	61	1963
Mr. Rashesh Chandrakant Gogri	MD & Executive Director	50	1974
Mr. Dhanaji L. Kakade	Vice President of Technical	-	-
Mr. Vishwa Harshit Savla	Managing Director of the Pinnacle Life Science Private Limited	-	-